Methamphetamine in Oklahoma: A Dual Crisis Alongside Opioids
Oklahoma faces both an opioid epidemic and a severe methamphetamine crisis. This guide examines Oklahoma's meth problem, its causes, community impact, and available treatment.
When Americans think about Oklahoma’s drug crisis, opioids and fentanyl often dominate the conversation. But running parallel to the opioid epidemic — and in many communities surpassing it in terms of arrests, hospitalizations, and family disruption — is Oklahoma’s severe and long-standing methamphetamine problem. Oklahoma has consistently ranked among the nation’s worst states for methamphetamine use, and understanding this crisis is essential for anyone trying to address addiction in the Sooner State.
The Scope of Oklahoma’s Meth Problem
The Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS) has consistently identified methamphetamine as one of the primary substances driving treatment admissions in Oklahoma. Unlike the opioid crisis, which spread from prescription pills through heroin to fentanyl in a relatively coherent chronological arc, methamphetamine has been a persistent feature of Oklahoma’s drug landscape for decades.
The Centers for Disease Control and Prevention (CDC) tracks stimulant-involved overdose deaths as a separate category from opioid deaths, and Oklahoma’s data shows significant methamphetamine contributions to overdose mortality — particularly as illicit fentanyl has been increasingly found mixed with methamphetamine supplies, often without users’ knowledge. This “polysubstance” reality means that people who use methamphetamine are at increasing risk of opioid overdose even if they are not intentionally using opioids.
The Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health consistently finds that methamphetamine use disorder affects a substantial portion of the Oklahoma population, and that meth-related treatment admissions in the state are among the highest per capita in the nation.
Why Oklahoma?
Several factors have contributed to Oklahoma’s elevated methamphetamine problem:
Geographic position: Oklahoma’s location along Interstate 35 and other major corridors has made it a distribution hub for drug trafficking organizations moving methamphetamine from Mexico northward. The majority of methamphetamine in Oklahoma today comes from large-scale production in Mexico rather than local labs.
Rural character: Methamphetamine has particular appeal in rural communities where it addresses real challenges — fatigue from demanding physical labor, long driving distances, limited entertainment options. In rural Oklahoma, where manufacturing jobs, agricultural work, and the oil patch have all experienced volatility, meth use has provided an illusory solution to exhaustion and economic despair.
Historical local production: Oklahoma was, in the early 2000s, one of the leading states for domestic methamphetamine production in small, improvised labs (“meth labs”). Legislation restricting pseudoephedrine purchases helped reduce local production significantly, but demand shifted to imported product rather than disappearing.
Co-occurring mental health conditions: The National Institute on Drug Abuse (NIDA) notes that methamphetamine use disorder frequently co-occurs with depression, anxiety, PTSD, and psychotic disorders — all of which are undertreated in Oklahoma’s rural and underserved communities.
What Methamphetamine Does to the Brain and Body
Methamphetamine works by causing a massive release of dopamine — the brain’s primary reward chemical — while also blocking its reuptake. This produces an intensely pleasurable rush followed by hours of alertness, energy, and euphoria. The experience is so reinforcing that the brain rapidly learns to prioritize meth above all other rewards.
With repeated use, the brain’s dopamine system is profoundly disrupted. According to NIDA, heavy methamphetamine use literally damages dopamine receptors and dopamine-producing neurons in ways visible on brain imaging. The consequences include:
Anhedonia: The inability to feel pleasure from normal activities. Without meth, nothing feels good. Food, sex, social interaction, accomplishment — all become flat and unsatisfying. This is one of the primary drivers of relapse.
Cognitive impairment: Chronic meth use damages memory, executive function, processing speed, and decision-making. These deficits can persist for months after stopping use, though research shows significant recovery with sustained abstinence.
Meth-induced psychosis: High doses or prolonged use can produce paranoid delusions, auditory and visual hallucinations, and behavior indistinguishable from paranoid schizophrenia. This condition — sometimes called “meth psychosis” or “stimulant psychosis” — can persist for weeks or months after the last use and may require antipsychotic medication.
Physical health effects: Methamphetamine causes severe dental decay (“meth mouth”) from dry mouth, teeth grinding, and poor dental hygiene. Skin picking and sores from formication (the sensation of bugs under the skin) are common. Weight loss, cardiovascular strain, and immune suppression are significant physical risks.
Mental health deterioration: Long-term meth use is associated with chronic depression, anxiety, paranoia, and significant social isolation.
The Intersection With Opioids
Oklahoma’s drug crisis is increasingly characterized by polysubstance use — people using multiple substances simultaneously or alternating between them. ODMHSAS data shows that a significant proportion of people admitted for methamphetamine treatment in Oklahoma also report opioid use, and vice versa.
Critically, illicit fentanyl has been found in Oklahoma’s methamphetamine supply. People who believe they are using only meth may inadvertently consume fentanyl — and because they have no opioid tolerance, even small amounts can be fatal. The CDC has documented this phenomenon across multiple states, and Oklahoma is no exception.
This overlap means that naloxone (Narcan) should be available even to people who use only stimulants, as a safety measure against accidental opioid exposure.
Treatment for Methamphetamine Addiction
There are currently no FDA-approved medications for methamphetamine use disorder, which makes meth treatment more challenging than opioid treatment. However, effective behavioral treatments exist and can produce significant recovery outcomes.
Cognitive Behavioral Therapy (CBT): CBT helps people identify the thoughts, feelings, and situations that trigger cravings and drug use, then develop coping strategies. NIDA identifies CBT as one of the most effective treatments for stimulant use disorders.
Contingency Management (CM): CM uses a structured system of rewards (vouchers, prizes) to reinforce abstinence and treatment engagement. It has the strongest evidence base of any behavioral treatment for methamphetamine use disorder, yet remains underutilized in Oklahoma.
The Matrix Model: A comprehensive outpatient program combining elements of CBT, contingency management, family education, and 12-step facilitation. It was developed specifically for stimulant use disorders.
Motivational Interviewing (MI): A counseling approach that helps people explore and resolve ambivalence about change. It is particularly useful in the early stages of treatment when motivation may be fragile.
Addressing co-occurring disorders: Because meth use disorder frequently co-occurs with depression, PTSD, and anxiety, integrated treatment that addresses both addiction and mental health simultaneously produces better outcomes than sequential treatment.
Residential treatment: For people with severe methamphetamine addiction, residential treatment provides the structured environment and distance from triggers needed for meaningful early recovery. Long-term residential options are particularly important given the extended duration of meth-related anhedonia.
ODMHSAS funds methamphetamine treatment services throughout Oklahoma, and SAMHSA’s treatment locator (findtreatment.gov) can identify programs accepting various payment sources.
Recovery Is Real — and Takes Time
Recovery from methamphetamine addiction is more protracted than recovery from many other substances due to the extent of dopamine system disruption. The first weeks and months are characterized by profound fatigue, depression, and craving. People in early meth recovery should be warned that this is a temporary neurological phenomenon — not a permanent state — because many relapse during this phase believing the depression will never lift.
With time, abstinence, and support, the brain’s dopamine system recovers substantially. NIDA research shows measurable brain recovery with sustained abstinence, with significant cognitive improvements over 12 to 24 months. Many people in long-term recovery from methamphetamine describe complete return to prior functioning and a quality of life they could not have imagined during active addiction.
Ready to Get Help?
Methamphetamine addiction is one of the most challenging substance use disorders — but it is treatable, and recovery is real. Oklahoma has the resources, and you deserve the chance to access them.
Call the Oklahoma Addiction Hotline today. Our specialists understand the specific challenges of methamphetamine addiction and can connect you with appropriate treatment programs in Oklahoma City, Tulsa, or wherever you are in the state. The call is free, completely confidential, and available any time of day or night.